Poland· PL-100488229
Tepkinly
A epcoritamab product containing epcoritamabum, registered in Poland by AbbVie Deutschland GmbH & Co. KG. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Epcoritamab is registered in 14 of 19 countries.
Countries holding a registration under ATC L01FX27 (epcoritamab), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Epcoritamab · ATC L01FX27
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of epcoritamab costs, country by country.
Normalised to the WHO defined daily dose (1.7 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Epcoritamab · price per daily dose (1.7 mg)
USD · FX 28 Sept 2026
- CH Switzerland$281.38
The record
At a glance
URPL (Poland)- Active substance
- Epcoritamabum
- Manufacturer
- AbbVie Deutschland GmbH & Co. KG
- Country
- Poland (PL)
- ATC code
- L01FX27
- ATC class
- Epcoritamab
- Defined daily dose
- 1.7 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin08054083026503
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Epcoritamab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandTepkinly 4 mg/0,8 ml, InjektionslösungAbbVie AG
- CzechiaTEPKINLYAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- SpainTEPKINLY 4 MG/0,8 ML SOLUCION INYECTABLEAbbvie Deutschland Gmbh & Co. Kg
- IcelandTepkinlyAbbVie Deutschland GmbH & Co. KG
- NorwayTepkinlyAbbVie Deutschland GmbH & Co
- SwedenTepkinly 4 mg/0,8 ml Injektionsvätska, lösningAbbVie Deutschland GmbH & Co KG
- United StatesEPKINLYGenmab US, Inc.
- CanadaEPKINLYABBVIE CORPORATION
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Tepkinly
- Iceland · Tepkinly
- Liechtenstein · Tepkinly
- Norway · Tepkinly
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3e0646ac-c50f-4919-b796-a845940edc8f GET /v1/drugs/3e0646ac-c50f-4919-b796-a845940edc8f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "4 mg/0,8 ml",
"packaging": "08054083026503 ¦ Rpz ¦ EU/1/23/1759/001 ¦ 151584\n1 fiol. 0,8 ml\n¦ UR/Z/4c/157/24 - 08054083026503 ¦ UR/Z/4c/172/23 - 08054083026503 ¦ UR/Z/4c/234/25 - 08054083026503",
"substance": "Epcoritamabum 4 mg/0.8 ml",
"common_name": "Epcoritamabum",
"pl_product_id": "100488229",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about epcoritamab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.